LNAI
Lunai Bioworks
LNAI
LNAI
39 hedge funds and large institutions have $3.73M invested in Lunai Bioworks in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 14 increasing their positions, 13 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
39
Holders Change
-4
Holders Change %
-9.3%
% of All Funds
0.63%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
14
Reduced
13
Closed
7
Calls
$13K
Puts
$27K
Net Calls
-$14K
Net Calls Change
-$124K
Top Buyers
| 1 |
BlackRock
New York
|
+$35.9K |
| 2 |
Belvedere Trading
Chicago,
Illinois
|
+$24.3K |
| 3 |
Millennium Management
New York
|
+$20.1K |
| 4 |
CF
Cantor Fitzgerald
New York
|
+$14.3K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$12K |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$79.9K |
| 2 |
Two Sigma Investments
New York
|
-$51.8K |
| 3 |
Rafferty Asset Management
New York
|
-$48K |
| 4 |
Two Sigma Advisers
New York
|
-$34.1K |
| 5 |
EMG
ETF Managers Group
Summit,
New Jersey
|
-$28K |
